Zuo Guo-Wei, Lü Feng-Lin
State Key Laboratory of Trauma Burns and Combined Injury, Infection & Immunology Department, Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Yi Chuan. 2005 Nov;27(6):995-1000.
Since the first report of the establishment of human artificial chromosome(HAC) was published in 1997, several types of HAC have been created by different strategies. Compared to other artificial chromosomes, such as yeast artificial chromosome (YAC) and bacterial artificial chromosome(BAC), HAC exists in a cell independently, in other words, HAC does not integrated into the cellular genome, and can undergo normal mitosis and meiosis from generation to generation in vitro and in vivo. Recent results proved that HAC, as a DNA carrier, is able to host a large fragment of DNA or mini-chromosome, thus it could be a very important tool in the study of human gene expression and regulation, human chromosome function and minimum functional elements and animal models for human diseases. In the near future, HAC can also be used in gene therapy for human genetic diseases.
自1997年首次报道人类人工染色体(HAC)构建成功以来,已通过不同策略创建了多种类型的HAC。与其他人工染色体,如酵母人工染色体(YAC)和细菌人工染色体(BAC)相比,HAC在细胞中独立存在,也就是说,HAC不整合到细胞基因组中,并且能够在体外和体内代代相传地进行正常的有丝分裂和减数分裂。最近的研究结果证明,作为一种DNA载体,HAC能够容纳大片段DNA或微型染色体,因此它可能成为研究人类基因表达与调控、人类染色体功能及最小功能元件以及人类疾病动物模型的非常重要的工具。在不久的将来,HAC还可用于人类遗传病的基因治疗。